Grace claims against Fresenius "absurd" say analysts
This article was originally published in Clinica
Executive Summary
Claims in litigation against WR Grace that dialysis company Fresenius paid less than fair value for its purchase of NMC from Grace in 1996 have been discounted as "absurd" by analysts at Morgan Stanley Dean Witter.